Table 5.
Major clinical outcome parameters in alloSCT patients according to time intervals between diagnosis of IA to alloSCT.
| Non-Relapse-Mortality | Total | Events | 1-year NRM (95% C.I.) | p |
|---|---|---|---|---|
| IA No or more than 6 months before | 1368 | 155 | 11.40 (9.78–13.16) | 0.5 |
| IA 3–5.9 months before | 30 | 5 | 16.94 (6.02–32.58) | |
| IA 0–2.9 months before | 41 | 6 | 14.63 (5.85–27.23) | |
|
Relapse incidence |
Total |
Events |
1-year RI (95% C.I.) |
p |
| IA No or more than 6 months before | 1368 | 249 | 18.26 (16.25–20.37) | 0.28 |
| IA 3–5.9 months before | 41 | 11 | 26.93 (14.35–41.21) | |
| IA 0–2.9 months before | 30 | 7 | 23.91 (10.30–40.64) | |
|
Progression-free survival |
Total |
Events |
1-year RFS (95% C.I.) |
p |
| IA No or more than 6 months before | 1368 | 404 | 70.34 (67.83–72.70) | 0.08 |
| IA 3–5.9 months before | 30 | 12 | 59.13 (39.34–74.38) | |
| IA 0–2.9 months before | 41 | 17 | 58.43 (41.91–71.75) | |
|
Overall survival |
Total |
Events |
1-year OS (95% C.I.) |
p |
| IA No or more than 6 months before | 1368 | 287 | 78.88 (76.61–80.96) | 0.077 |
| IA 3–5.9 months before | 30 | 10 | 65.97 (45.95–80.05) | |
| IA 0–2.9 months before | 41 | 12 | 70.65 (54.13–82.14) |